Age-appropriate vaccination and associated factors among children aged 12–35 months in Ethiopia: A multi-level analysis.

Autor: Worku, Bekelu Teka¹ (AUTHOR), Wordofa, Eshetu Alemayehu² (AUTHOR), Senbeto, Gadisa³ (AUTHOR), Zinab, Beakal⁴ (AUTHOR), Kebede, Ebissa Bayana⁵ (AUTHOR) ebisabayana@ymail.com, Abamecha, Fira⁶ (AUTHOR), Debela, Gurmessa Tura¹ (AUTHOR), Birhanu, Negalign⁷ (AUTHOR), Siraneh, Yibeltal⁷ (AUTHOR), Tamiru, Dessalegn⁴ (AUTHOR)

Publikováno v: PLoS ONE. 10/10/2024, Vol. 19 Issue 10, p1-13. 13p.

Progresses Toward Polio Eradication in Asian Countries: Its History and Japan's Contributions.

Autor: Toizumi M; From the Department of Pediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan., Takamatsu M; World Health Organization Papua New Guinea, Port Moresby, Papua New Guinea.; Health and Global Policy Institute, Tokyo, Japan., Toda K; Immunization Center, Akita Red Cross Hospital, Akita, Japan., Horikoshi Y; Division of Infectious Diseases, Department of Pediatrics, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.

Publikováno v: The Pediatric infectious disease journal [Pediatr Infect Dis J] 2024 Oct 01; Vol. 43 (10), pp. e347-e353. Date of Electronic Publication: 2024 Jul 22.

Geographic information system and information visualization capacity building: Successful polio eradication and current and future challenges in the COVID-19 era for the World Health Organization's African region.

Autor: Kipterer, John Kapoi¹ (AUTHOR) jkipterer@who.int, Touray, Kebba¹ (AUTHOR), Godwin, Akpan Ubong¹ (AUTHOR), Cisse, Aboubakar¹ (AUTHOR), Aimee, Babona Nshuti Marie¹ (AUTHOR), Busisiwe, Ngobe¹ (AUTHOR), Derrick, Chefor Ymele Demeveng¹ (AUTHOR), Henry, Green Hugh¹ (AUTHOR), Modjirom, Ndoutabe¹ (AUTHOR), Seaman, Vince² (AUTHOR), Ahmed, Jamal¹ (AUTHOR)

Publikováno v: PLoS ONE. 8/15/2024, Vol. 19 Issue 8, p1-13. 13p.

Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.

Autor: Shaw J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Jorba J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Zhao K; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Iber J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chen Q; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adu F; Department of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Adeniji A; Department of Virology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Bukbuk D; University of Maiduguri Teaching Hospital, Maiduguri, Nigeria., Baba M; University of Maiduguri Teaching Hospital, Maiduguri, Nigeria., Henderson E; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dybdahl-Sissoko N; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., McDonald S; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Weldon WC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Gumede N; Virology Division, National Institute of Communicable Diseases, Johannesburg, South Africa., Oberste MS; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Kew OM; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Burns CC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA CBurns@cdc.gov.

Publikováno v: Journal of virology [J Virol] 2018 Apr 13; Vol. 92 (9). Date of Electronic Publication: 2018 Apr 13 (Print Publication: 2018).

Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?

Autor: Zhao K; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Jorba J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Shaw J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Iber J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Chen Q; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA., Bullard K; IHRC Inc., Atlanta, GA 30329, USA., Kew OM; Task Force for Global Health, Decatur, GA 30030, USA., Burns CC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30329, USA.

Publikováno v: Computational and structural biotechnology journal [Comput Struct Biotechnol J] 2017 Oct 12; Vol. 15, pp. 456-462. Date of Electronic Publication: 2017 Oct 12 (Print Publication: 2017).